Sunny outlook at Informex 2011
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Sunny outlook at Informex 2011

5:08 PM, 8th June 2011
Sunny outlook at Informex 2011

 

Fine Chemicals: Companies at custom chemicals trade show express optimism, reveal investments.

 

CHARLOTTE, US: Fine and custom chemicals executives at the annual Informex conference in Charlotte, USA, last week were sanguine about the year ahead, and several companies announced investments in areas including high-potency active pharmaceutical ingredients (APIs) and final-dosage formulation. Still, persistent overcapacity across the sector continues to cloud forecasts.

 

Fabbrica Italiana Sintetici recently spent about $ 1.6 million on new lyophilization capacity at its main site in Vicenza, Italy, according to FIS's General Manager Roger LaForce. Technology was transferred from a partner, Canada's Delmar Chemicals. Thanks to healthy business in both custom APIs and generic drugs, FIS's sales grew about 12 per cent last year to $ 244 million, LaForce said.

 

Boehringer Ingelheim is building a high-containment finished-drug-services plant in Columbus, Ohio, that will produce liquids, solids, and tablets, according to Dennis Seagle, head of the firm's pharma chemicals business. The company, which already conducts captive-use formulation at sites in Greece, Brazil, and Indonesia, will split capacity in Columbus between captive use and the merchant market, Seagle said.

 

Asia continues to win investment. Flamma, a Bergamo, Italy-based API manufacturer, has committed to a $ 4 million investment in China, said Kenneth N Drew, Flamma's director of US sales and business development. Capacity at the company's three-year-old advanced intermediates and chiral materials plant in Dalian will be more than doubled to 100 metric tons by the end of the year and then doubled again in 2012.

 

At its site in Dewas, India, Navin Fluorine plans to open a pharmaceutical-quality fluorine chemicals pilot plant this month, followed by a large-scale facility later this year. Some 30–35 per cent of drug molecules in development contain fluorine, said Ashis Mukherjee, Navin's director of contract manufacturing. He anticipates business with firms now reliant on Chinese suppliers.

 

Executives fretted that new capacity isn't being offset by shutdowns. Johnson Matthey, for example, has more than doubled its controlled-substance capacity to 65,000 gal with its recent purchase of a Lonza facility in Conshohocken, Pa. The company, which operates a controlled-substance plant in West Deptford, NJ, sees steady growth in opiates, said Jennifer O'Sullivan, product manager for Johnson Matthey's pharmaceutical materials division. Lonza had announced in 2010 that it would shut the plant down.

© 2011 American Chemical Society 

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Israel Chemicals completes $ 270 million Scotts Global Pro acquisition

The acquisition will double Israel Chemicals’s specialty fertilizer activities that totaled $ 250 million in 2009, about 10 per cent of the co ...

Read more
BASF offers innovative barrier solutions for packaging industry

BASF offers a variety of barrier solutions for the packaging industry that demonstrate a high effectiveness in preventing mineral oil residues from mi ...

Read more
INEOS is offered $ 1 billion by PetroChina for a 50 per cent share

HAMPSHIRE, UK: Recently PetroChina International (London) Co Ltd submitted an irrevocable offer to INEOS of $ 1,015,000,000 for a 50 per cent share in ...

Read more
Kemira Oyj’s reports strong financial performance; expects growth in emerging markets

HELSINKI, FINLAND: Looking at the growing demand, Kemira expects the volume recovery that was seen in 2010 to continue in 2011 and its revenue is ex ...

Read more
AkzoNobel posts strong revenue growth

Stronger volumes and pricing drive revenue growth of 16 percent to € 3.8 billion EBITDA increased 10 per cent to € 437 million Total net ...

Read more
INEOS and Sinopec JV to build a 400,000 tonne phenol plant in China

LONDON, UK: INEOS Phenol and Sinopec Yangzi Petrochemical Company recently signed a MOU, agreeing the framework for the design and future operation ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X